Ocular immune privilege in the year 2010: Ocular immune privilege and uveitis

Ocular Immunology and Inflammation

Volumn 18, Issue 6, 2010, Pages 488-492

  Taylor, Andrew W ^a   Kaplan, Henry J ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

adaptive immunity; autoimmunity; immune privilege; innate immunity; uveitis

Indexed keywords

ALLOGRAFT; EYE INFLAMMATION; EYE PROTECTION; HUMAN; IMMUNITY; PATHOPHYSIOLOGY; RETINA FOVEA; REVIEW; UVEITIS;

ADAPTIVE IMMUNITY; ANIMALS; ANTERIOR CHAMBER; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLLAGEN; DISEASE MODELS, ANIMAL; EYE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNOSUPPRESSION; INFLAMMATION; NATURAL KILLER T-CELLS; UVEITIS;

EID: 78649307579     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.525730     Document Type: Review

References (58)

1. Medawar P. Immunity to homologous grafted skin, III: the fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29:58-69.
2. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye, I: F1 lymphocyte induced-immune deviation. J Immunol. 1977;118:809-814.
3. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and infammation. J Leukoc Biol. 2003;74:179-185.
4. Wilbanks GA, Streilein JW. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen: evidence for active suppression of IgG2-secreting B lymphocytes. Immunology. 1990;71:566-572.
5. Kaplan HJ, Streilein JE. Immune response to immunization via the anterior chamber of the eye, I: F1 lymphocyte induced-immune deviation. J Immunol. 1977;118:809-814.
6. Lin HH, Faunce DE, Stacey M, et al. The macrophage F4/80 receptor is required for the induction of antigen-specifc efferent regulatory T cells in peripheral tolerance. J Exp Med. 2005;201:1615-1625.
7. Sonoda KH, Stein-Streilein J. Ocular immune privilege and CD1d-reactive natural killer T cells. Cornea. 2002;21:S33-S38.
8. D'Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology. 1998;95:47-55.
9. Li X, Taylor S, Zegarelli B, Shen S, O'Rourke J, Cone RE. The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system. J Neuroimmunol. 2004;153:40-49.
10. Vega JL, Keino H, Masli S. Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege. Am J Pathol. 2009;175:1218-1225.
11. Taylor AW, Streilein JW, Cousins SW. Identifcation of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-1206.
12. Taylor AW, Streilein JW, Cousins SW: Immunoreactive vasoactive intestinal peptide contributes to the immuno-suppressive activity of normal aqueous humor. J Immunol 1994;153:1080-1086.
13. Taylor AW, Yee DG, Streilein JW. Suppression of nitric oxide generated by infammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci. 1998;39:1372-1378.
14. Taylor AW, Yee DG. Somatostatin is an immunosuppres-sive factor in aqueous humor. Invest Ophthalmol Vis Sci. 2003;44:2644-2649.
15. Ryu YH, Kim JC. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosup-pressive factor. Invest Ophthalmol Vis Sci. 2007;48:4148-4152.
16. Griffth TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995; 270:1189-1192.
17. Usui Y, Okunuki Y, Hattori T, et al. Functional expression of B7H1 on retinal pigment epithelial cells. Exp Eye Res. 2008; 86:52-59.
18. Sugita S, Usui Y, Horie S, et al. T-cell suppression by programmed cell death ligand 1 on retinal pigment epithelium during infammatory conditions. Invest Ophthalmol Vis Sci. 2009; 50:2862-2870.
19. Sugita S, Horie S, Nakamura O, et al. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during infammatory conditions. J Immunol. 2009; 183:5013-5022.
20. Sugita S, Horie S, Nakamura O, et al. Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol. 2008; 181:7525-7536.
21. Horie S, Sugita S, Futagami Y, et al. Human iris pigment epithelium suppresses activation of bystander T cells via TGFbeta-TGFbeta receptor interaction. Exp Eye Res. 2009; 88:1033-1042.
22. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM. The neuropeptide alpha-MSH has specifc receptors on neutrophils and reduces chemotaxis in vitro. Peptides. 1996;17:675-679.
23. Masli S, Turpie B, Hecker KH, Streilein JW. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J Immunol. 2002;168:2264-2273.
24. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol. 1998;160:5693-5696.
25. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci. 2005;46:908-919.
26. Atkinson JP, Farries T: Separation of self from non-self in the complement system. Immunol Today. 1987;8:212-215.
27. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci. 2000; 41(11): 3492-3502.
28. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med. 2003;9:206-212.
29. Jiang G, Ke Y, Sun D, Wang Y, Kaplan HJ, Shao. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest Ophthalmol Vis Sci. 2009; 50(10): 4769-4776.
30. Taylor AW, Alard P, Yee DG, Streilein JW. Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T cells. Curr Eye Res. 1997;16:900-908.
31. Nishida T, Taylor AW. Specifc aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci. 1999;40:2268-2274.
32. Streilein JW, Masli S, Takeuchi M, Kezuka T. The eye's view of antigen presentation. Hum Immunol. 2002;63:435-443.
33. Taylor AW, Streilein JW, Cousins SW. Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation. 1994;1:188-194.
34. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14:303-308.
35. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis: incidence and prevalence in a small urban community. Arch Ophthalmol. 1962;68:502-514.
36. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491-500.
37. Knox EG, Mayho A, Cant W, Truelove P. Iridocyclitis: incidence, distribution and health service usage. Community Med. 1980;2:97-101.
38. Wacker WB, Donoso LA, Kalsow CM, Yankeelov JA Jr, Organisciack DT. Experimental allergic uveitis: isolation, characterization and localization of a soluble uveito-pathogenic antigen from the bovine retina. J Immunol. 1977;119:1949-1958.
39. Gery I, Wiggert B, Redmond RM, et al. Uveoretinitis and pinealitis induced by immunization with interphotore-ceptor retinoid-binding protein. Invest Ophthalmol Vis Sci. 1986;27:1296-1300.
40. Schalkin JJ, Winkens HJ, Van Vugt AH, Bovee-Geurts PHM, deGrip WJ, Broekhuyse RM. Rhodopsin-induced experimental autoimmune uveoretinitis: dose-dependent clinico-pathological features. Exp Eye Res. 1988;47:135-145.
41. Bora NS, Sohn JH, Kang SG, et al. Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol. 2004;172:7086-7094.
42. Ichikawa T, Taguchi O, Takahashi T, et al. Spontaneous development of autoimmune uveoretinitis in nude mice following reconstitution with embryonic rat thymus. Clin Exp Immunol. 1991;86:112-117.
43. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298:1395-1401.
44. Ohta K, Wiggert B, Yamagami S, Taylor AW, Streilein JW. Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis. J Immunol. 2000;164:1185-1192.
45. Kitaichi N, Namba K, Taylor AW. Inducible immune regulation following autoimmune disease in the immune privileged eye. J Leuk Biol. 2005; 77:496-502.
46. Taylor AW, Kitaichi N, Biros D. Melanocortin 5 receptor and ocular immunity. Cell Mol Biol. 2006; 52:53-59.
47. Mondino BJ, Glovsky MM, Ghekiere L. Activated complement in infamed aqueous humor. Invest Ophthalmol Vis Sci. 1985;25:871-873.
48. Sugita S, Takase H, Taguchi C, Mochizuki M. The role of soluble TNF receptors for TNF-alpha in uveitis. Invest Ophthalmol Vis Sci. 2007;48:3246-3252.
49. Banerjee S, Savant V, Scott RA, Curnow SJ, Wallace GR, Murray PI.Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci. 2007;48:2203-2207.
50. Curnow SJ, Falciani F, Durrani OM, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profles in uveitis. Invest Ophthalmol Vis Sci. 2005;46:4251-4259.
51. Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS. Elevated levels of interleukin 6 in the vitreous fuid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Infamm. 2004;12:193-201.
52. Murphy CC, Greiner K, Plskova J, et al. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis. Arch Ophthalmol. 2004;122:845-851.
53. Kotake S, Kitaichi N, Ohno S. Macrophage migration inhibitory factor in uveitis. Int Ophthalmol Clin. 2002;42: 99-103.
54. Sugita S, Taguchi C, Takase H, et al. Soluble Fas ligand and soluble Fas in ocular fuid of patients with uveitis. Br J Ophthalmol. 2000;84:1130-1134.
55. Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fuid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659-2665.
56. de Boer JH, Limpens J, Orengo-Nania S, de Jong PT, La Heij E, Kijlstra A. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci. 1994;35:3702-3710.
57. Murray PI, Hoekzema R, van Haren MA, de Hon FD, Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci. 1990;31:917-920.
58. Curnow SJ, Murray PI. Infammatory mediators of uveitis: cytokines and chemokines. Curr Opin Ophthalmol. 2006;17:532-537.